Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

17.89
Delayed Data
As of 11:01am ET
 -0.06 / -0.33%
Today’s Change
9.06
Today|||52-Week Range
42.25
-33.00%
Year-to-Date

Today’s Trading

Previous close17.95
Today’s open18.48
Day’s range17.04 - 18.50
Volume88,533
Average volume (3 months)762,191
Market cap$645.7M
Dividend yield--
Data as of 11:01am ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+16.08%
Earnings growth (this year)+5.01%
Earnings growth (next 5 years)+56.17%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.32

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...-0.23-4.39%
MACKMerrimack Pharmaceut...-0.27-4.91%
CLLSCellectis SA-0.24-1.24%
SUPNSupernus Pharmaceuti...+0.01+0.08%
Data as of 11:15am ET, 02/12/2016

Financials

Next reporting dateMarch 28, 2016
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$0.00
Annual profit (last year)-$76.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts

Partner Offers